权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection

通过靶向病毒感染后的簇细胞改善肺再生

基本信息

批准号：
10471373
负责人：
Jianwen Que
金额：
$ 58.55万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-08-20 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10471373
关键词：
2019-nCoV Ablation Acute Lung Injury Address Alternative Therapies Alveolar Alveolar Cell Alveolus Attenuated Basal Cell Brush Cell COVID-19 COVID-19 pandemic COVID-19 pandemic effects COVID-19 patient Cations Cell Differentiation process Cells Chemosensitization Chronic Disease Clinical Coronavirus Data Disease Distal Epithelial Cells Exhibits Fibrosis Financial Hardship Foundations Genetic Genetic Transcription Goblet Cells Health Hyperplasia Impairment In Situ Hybridization Infection Inflammation Influenza Influenza A Virus, H1N1 Subtype Intestines Knock-in Mouse Ligands Lung Lung diseases Mediating Metaplasia Modeling Molecular Mucous body substance Mus Natural regeneration Organoids Oxides Pathway interactions Peripheral Persons Pharmacologic Substance Phase Play Reagent Role SARS-CoV-2 infection Signal Transduction Structure Structure of parenchyma of lung TRPM5 gene Testing Tissues Virus Virus Diseases acute infection alveolar epithelium antagonist cell type cytokine directed differentiation efficacy testing experimental study flu helminth infection improved influenza infection insight lung development lung injury lung regeneration mortality mouse model notch protein novel novel strategies novel therapeutic intervention paracrine receptor regeneration function repaired seasonal influenza single cell analysis stem cells targeted treatment therapeutic target triphenylphosphine

项目摘要

ABSTRACT Seasonal influenza and the current COVID-19 pandemic cause serious health and financial burdens. Severe viral infection leads to acute lung injury, inflammation and contributes to tissue remodeling and fibrosis. Intriguingly, clusters of ectopic basal cells (also known as pod cells) are present in the peripheral lungs during acute infection and remodeling phases. Initial studies indicated that these cells were able to generate type I and II alveolar epithelial cells (AECs). Nevertheless, subsequent lineage tracing studies revealed that pod cells had minimal if any contribution to alveolar regeneration. Moreover, our preliminary data suggest that pod cells give rise to goblet cells, resulting in mucous metaplasia accompanied by the presence of chemosensory tuft cells (also known as brush cells). Significantly, genetic ablation of tuft cells promotes the differentiation of pod cells into AECs. Our further analyses revealed that tuft cells express the Notch ligand Jag2, whereas pod cells express Notch receptors with prominent Notch activation. Consistently, Notch inhibition led to reduced mucous metaplasia and improved alveolar regeneration. We therefore hypothesize that tuft cells promote mucous metaplasia of pod cells and impede alveolar regeneration via paracrine JAG2/Notch activation upon viral infection. Two specific aims were devised to test the hypothesis. Aim1: To address the molecular mechanisms by which tuft cells promote mucous metaplasia following viral infection. Aim2: To promote the differentiation of pod cells into AECs through targeting JAG2 in tuft cells. In this aim we will combine a novel COVID-19 mouse model and pod cell organoids established from COVID-19 patient lungs to test the efficacy of a JAG/Notch decoy in promoting alveolar regeneration. Together this proposal will not only elucidate the disease mechanisms impairing lung regeneration post viral infection, but also offer new therapeutic approaches to treat lungs infected by influenza and coronavirus.

摘要